Francois et al. (85) reported that intramuscular administration of rhIL-7 in patients with sepsis increased the number of lymphocytes and their subsets, as well as IL-10 levels; however, mortality remained unchanged, suggesting that immune recovery alone may be insufficient to reverse severe infection and organ damage. This evidence concerns the gene IL10 and Sepsis.